Vaxxinity, Inc. VAXX
We take great care to ensure that the data presented and summarized in this overview for Vaxxinity, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in VAXX
Top Purchases
Top Sells
About VAXX
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.
Insider Transactions at VAXX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,872
-0.29%
|
$22,872
$1.67 P/Share
|
|
Sep 08
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,089
-0.29%
|
$25,089
$1.67 P/Share
|
|
Sep 07
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,516
-0.23%
|
$18,516
$1.79 P/Share
|
|
Sep 07
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,312
-0.23%
|
$20,312
$1.79 P/Share
|
|
Sep 06
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,839
-0.06%
|
$4,839
$1.88 P/Share
|
|
Sep 06
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,308
-0.06%
|
$5,308
$1.88 P/Share
|
|
Apr 26
2023
|
Peter Diamandis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
475,537
+19.09%
|
$0
$0.89 P/Share
|
|
Jan 23
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
405,217
-4.42%
|
$1,215,651
$3.35 P/Share
|
|
Jan 23
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
95,475
-4.42%
|
$286,425
$3.35 P/Share
|
|
Dec 02
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,121
-0.12%
|
$22,242
$2.57 P/Share
|
|
Dec 02
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,620
-0.12%
|
$5,240
$2.57 P/Share
|
|
Dec 01
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
270,964
-2.87%
|
$541,928
$2.97 P/Share
|
|
Dec 01
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
63,843
-2.87%
|
$127,686
$2.97 P/Share
|
|
Sep 06
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,243
-0.27%
|
$50,486
$2.4 P/Share
|
|
Sep 06
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,115
-0.27%
|
$24,230
$2.4 P/Share
|
|
Aug 25
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
22,757
-0.24%
|
$45,514
$2.33 P/Share
|
|
Aug 25
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,923
-0.24%
|
$21,846
$2.33 P/Share
|
|
Aug 24
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
83,786
-0.87%
|
$167,572
$2.39 P/Share
|
|
Aug 24
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,214
-0.87%
|
$80,428
$2.39 P/Share
|
|
Aug 23
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
33,785
-0.35%
|
$67,570
$2.45 P/Share
|